Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus

dc.contributor.authorMu, Qinghuien
dc.contributor.authorEdwards, Michael R.en
dc.contributor.authorSwartwout, Brianna K.en
dc.contributor.authorCabana-Puig, Xavieren
dc.contributor.authorMao, Jiangdien
dc.contributor.authorZhu, Jingen
dc.contributor.authorGrieco, Joseph P.en
dc.contributor.authorCecere, Thomas E.en
dc.contributor.authorPrakash, Meetaen
dc.contributor.authorReilly, Christopher M.en
dc.contributor.authorPuglisi, Christopheren
dc.contributor.authorBachali, Prathyushaen
dc.contributor.authorGrammer, Amrie C.en
dc.contributor.authorLipsky, Peter E.en
dc.contributor.authorLuo, Xin M.en
dc.contributor.departmentVirginia Tech Carilion School of Medicineen
dc.contributor.departmentBiomedical Sciences and Pathobiologyen
dc.description.abstractAutoimmune diseases, such as systemic lupus erythematosus, are characterized by excessive inflammation in response to self-antigens. Loss of appropriate immunoregulatory mechanisms contribute to disease exacerbation. We previously showed the suppressive effect of vancomycin treatment during the "active-disease" stage of lupus. In this study, we sought to understand the effect of the same treatment given before disease onset. To develop a model in which to test the regulatory role of the gut microbiota in modifying autoimmunity, we treated lupus-prone mice with vancomycin in the period before disease development (3-8 weeks of age). We found that administration of vancomycin to female MRL/lpr mice early, only during the pre-disease period but not from 3 to 15 weeks of age, led to disease exacerbation. Early vancomycin administration also reduced splenic regulatory B (Breg) cell numbers, as well as reduced circulating IL-10 and IL-35 in 8-week old mice. Further, we found that during the pre-disease period, administration of activated IL-10 producing Breg cells to mice treated with vancomycin suppressed lupus initiation, and that bacterial DNA from the gut microbiota was an inducer of Breg function. Oral gavage of bacterial DNA to mice treated with vancomycin increased Breg cells in the spleen and mesenteric lymph node at 8 weeks of age and reduced autoimmune disease severity at 15 weeks. This work suggests that a form of oral tolerance induced by bacterial DNA-mediated expansion of Breg cells suppress disease onset in the autoimmune-prone MRL/lpr mouse model. Future studies are warranted to further define the mechanism behind bacterial DNA promoting Breg cells.en
dc.description.notesNIAMS AR073240, AR067418 (XL).en
dc.description.sponsorshipNIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [AR073240, AR067418]en
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.subjectsystemic lupus erythematosusen
dc.subjectgut microbiotaen
dc.subjectbacterial DNAen
dc.titleGut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupusen
dc.title.serialFrontiers in Immunologyen
dc.typeArticle - Refereeden


Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.35 MB
Adobe Portable Document Format